奎斯特诊疗(DGX)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 DGX 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement Q1 2026
Item	Category	Value	YoY
Net revenues	revenue	2.90B	9.16%
Operating income	profit	399.00M	15.32%
Total operating costs and expenses, net	cost	2.50B	8.24%
Equity in earnings of equity method investees, net of taxes	revenue	4.00M	-77.78%
Income before income taxes and equity in earnings of equity method investees	profit	334.00M	21.01%
Non-operating expense, net	revenue	65.00M	-7.14%
Cost of services	cost	1.95B	9.17%
Selling, general and administrative	cost	504.00M	5.88%
Amortization expense	cost	37.00M	-5.13%
Other operating income (expense), net	revenue	2.00M	0.00%
Aggregate	revenue	338.00M	14.97%
Interest expense, net	revenue	63.00M	-5.97%
Other expense, net	revenue	2.00M	-33.33%
Net income	profit	264.00M	12.34%
Income tax expense (benefit)	cost	74.00M	25.42%
Net income attributable to quest diagnostics	profit	252.00M	14.55%
Less: net income attributable to noncontrolling interests	cost	12.00M	-20.00%

Business Breakdown
Segment	Value	YoY
Diagnostic Information Services Business	2.83B	9.39%
Other Operating	63.00M	0.00%

Balance Sheet Q1 2026
Item	Category	Value
Accounts receivable, net of allowance for credit losses of $27 and $25 as of march 31, 2026 and december 31, 2025, respectively	assets	1.59B
Cash and cash equivalents	assets	393.00M
Prepaid expenses and other current assets	assets	361.00M
Inventories	assets	225.00M
Total current assets	assets	2.57B
Goodwill	assets	9.12B
Property, plant and equipment, net	assets	2.19B
Intangible assets, net	assets	1.72B
Operating lease right-of-use assets	assets	691.00M
Other assets	assets	256.00M
Investments in equity method investees	assets	134.00M
Total assets	assets	16.67B
Total stockholders’ equity	liabilities	7.67B
Long-term debt and lease obligation	liabilities	5.16B
Total current liabilities	liabilities	2.18B
Other liabilities	liabilities	1.02B
Long-term operating lease liabilities	liabilities	574.00M
Redeemable noncontrolling interest	liabilities	79.00M
Noncontrolling interests	liabilities	300.00M
Treasury stock, value	equity	5.09B
Accumulated other comprehensive loss	equity	43.00M
Total quest diagnostics stockholders’ equity	equity	7.37B
Accounts payable and accrued expenses	liabilities	1.50B
Long-term debt, current maturities	liabilities	503.00M
Current portion of long-term operating lease liabilities	liabilities	174.00M
Aggregate	equity	12.50B
Retained earnings	equity	10.15B
Additional paid-in capital	equity	2.35B
Common stock, par value $0.01 per share; 600 shares authorized as of both march 31, 2026 and december 31, 2025; 162 shares issued as of both march 31, 2026 and december 31, 2025	equity	2.00M

Operating Activities – 3M 2026
Item	Value
Net income	264.00M
Depreciation and amortization	147.00M
Deferred income tax expense	48.00M
Stock-based compensation expense	20.00M
Income taxes payable	13.00M
Other noncash income (expense)	8.00M
Provision for credit losses	1.00M
Accounts payable and accrued expenses	-12.00M
Increase (decrease) in other operating assets and liabilities, net	-31.00M
Increase (decrease) in accounts receivable	-180.00M

Investing Activities – 3M 2026
Item	Value
Payments to acquire businesses, net of cash acquired	-38.00M
Payments to acquire property, plant, and equipment	-114.00M

Financing Activities – 3M 2026
Item	Value
Exercise of stock options	65.00M
Repayments of debt	-1.00M
Payments of ordinary dividends, noncontrolling interest	-7.00M
Payment, tax withholding, share-based payment arrangement	-37.00M
Other financing activities, net	-84.00M
Payments of ordinary dividends, common stock	-88.00M

Cash Balance – 3M 2026
Item	Value
Cash and cash equivalents, beginning of period	420.00M
Cash and cash equivalents, end of period	393.00M